Abl Bio, Inc.
Clinical trials sponsored by Abl Bio, Inc., explained in plain language.
-
New hope for tough cancers: first patients to receive experimental drug
Disease control Recruiting nowThis is the first time a new drug called ABL103 is being tested in people. The main goal is to find a safe and tolerable dose for adults with advanced solid tumors that have gotten worse despite standard treatments. The study will also look for early signs that the drug might hel…
Phase: PHASE1 • Sponsor: ABL Bio, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New cancer drug combo targets tough tumors in early trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called ABL103, given alongside an existing immunotherapy (pembrolizumab) and sometimes with chemotherapy. It aims to see if this combination is safe and can help control advanced solid tumors that have stopped responding to standard tr…
Phase: PHASE1, PHASE2 • Sponsor: ABL Bio, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC